4.5 Review

Drafting the proteome landscape of myeloid-derived suppressor cells

期刊

PROTEOMICS
卷 16, 期 2, 页码 367-378

出版社

WILEY
DOI: 10.1002/pmic.201500229

关键词

Biomedicine; Mass spectrometry; Myeloid-derived suppressor cell; Pathway; Proteomics

资金

  1. Miguel Servet Fellowship [CP12/03114]
  2. FIS project grant from the Instituto de Salud Carlos III, Spain [PI14/00579]
  3. Refbio transpyrenaic collaborative project grants (NTBM and ncRNAbc)
  4. Sandra Ibarra Foundation
  5. Gobierno de Navarra Grant (BMED) [033-2014]
  6. Basque government BioEf project grant
  7. Gobierno de Navarra (BMED) [033-2014]
  8. Bioef (Basque government)
  9. RefBio NTBM grant
  10. Government of Navarra
  11. Spanish Ministry of Economy and Competitiveness
  12. PE I+D+I - ISCIII [PT13/0001]
  13. FEDER

向作者/读者索取更多资源

Myeloid-derived suppressor cells (MDSCs) are a heterogeneous population of cells that are defined by their myeloid origin, immature state, and ability to potently suppress T-cell responses. They regulate immune responses and the population significantly increases in the tumor microenvironment of patients with glioma and other malignant tumors. For their study, MDSCs are usually isolated from the spleen or directly of tumors from a large number of tumor-bearing mice although promising ex vivo differentiated MDSC production systems have been recently developed. During the last years, proteomics has emerged as a powerful approach to analyze MDSCs proteomes using shotgun-based mass spectrometry (MS), providing functional information about cellular homeostasis and metabolic state at a global level. Here, we will revise recent proteome profiling studies performed in MDSCs from different origins. Moreover, we will perform an integrative functional analysis of the protein compilation derived from these large-scale proteomic studies in order to obtain a comprehensive view of MDSCs biology. Finally, we will also discuss the potential application of high-throughput proteomic approaches to study global proteome dynamics and post-translational modifications (PTMs) during the differentiation process of MDSCs that will greatly boost the identification of novel MDSC-specific therapeutic targets to apply in cancer immunotherapy.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.5
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据